Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the current stage of apotex's ruxolitinib generic development in the us?Xeljanz xr 11 mg price?What strategies does pfizer use to maintain lipitor sales?Repatha patent expiration?How does lipitor's side effect profile change with age?
See the DrugPatentWatch profile for ajovy
Ajovy Safety in Pregnancy and Nursing Ajovy, a medication used to treat migraines, contains the active ingredient fremanezumab. Like other monoclonal antibodies, its safety during pregnancy and breastfeeding is not well understood. [1] Pregnancy Considerations There are limited data on the use of Ajovy during pregnancy. Fremanezumab has not been evaluated in human studies for safety in pregnant women, which is a major concern when considering treatment options for migraines during pregnancy. [1] In animal studies, there were findings of increased fetal deaths and reduced body weight in offspring at high doses. However, these results are not necessarily indicative of human risk. [1] Breastfeeding Concerns It is also unclear whether Ajovy passes into breast milk. Since fremanezumab is a large molecule, it is less likely to be excreted into breast milk in significant amounts. However, manufacturers typically recommend caution when breastfeeding, as a precautionary measure. [1] Mothers taking Ajovy should consult their healthcare provider for individualized advice on breastfeeding and medication use. Risk vs. Benefits When evaluating treatment options during pregnancy or breastfeeding, it is essential to weigh the benefits against the potential risks. While migraines can pose risks for pregnant women, including increased blood pressure and stroke, untreated migraines may also have adverse effects. What to Discuss with Your Healthcare Provider 1. Potential risks: Share your concerns about Ajovy's impact on your baby's development and growth. 2. Alternative treatments: Explore other options, like triptans or botulinum toxin, which have been studied to some extent in pregnant women. 3. Personalized approach: Discuss the latest research and your individual circumstances to make an informed decision. 4. Breastfeeding support: Get guidance on safely managing medication use while breastfeeding. Sources: [1] https://drugs.com/ppa/fremanezumab.html (Accessed May 24, 2024)
Other Questions About Ajovy :